✦ LIBER ✦

TACE combined with PEI versus TACE alone in the treatment of HCC: a meta-analysis

✍ Scribed by Na Wang; Quanlin Guan; Kai Wang; Bingdong Zhu; Wenzhen Yuan; Peng Zhao; Xiaowei Wang; Yongxun Zhao

Book ID: 107577236
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 316 KB
Volume: 28
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-010-9620-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Psychotherapy versus the combination of

Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis

✍ Pim Cuijpers; Annemieke van Straten; Lisanne Warmerdam; Gerhard Andersson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Combination of oral non-absorbable and i

Combination of oral non-absorbable and intravenous antibiotics versus intravenous antibiotics alone in the prevention of surgical site infections after colorectal surgery: a meta-analysis of randomized controlled trials

✍ C. F. Bellows; K. T. Mills; T. N. Kelly; G. Gagliardi 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 842 KB

The PREMIER study: A multicenter, random

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

✍ Ferdinand C. Breedveld; Michael H. Weisman; Arthur F. Kavanaugh; Stanley B. Cohe 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

Cost-effectiveness analysis of anastrozo

Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial

✍ Gershon Y. Locker; Robert Mansel; David Cella; Deborah Dobrez; Sonja Sorensen; S 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB

Anastrozole versus megestrol acetate in

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma : Results of a survival update based on a combined analysis of data from two mature phase III trials

✍ Aman U. Buzdar; Walter Jonat; Anthony Howell; Stephen E. Jones; Carl P. Blomqvis 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

Medical University of BACKGROUND. This report presents the results of a survival update based on the combined data from two studies that compared the efficacy and tolerability of anastrozole (1 or 10 mg once daily), a selective, nonsteroidal aromatase inhibitor administered orally, and megestrol ace